Huangqi Duan

Serum Metabolite Biomarkers Predictive of Response to PD-1 Blockade Therapy in Non-Small Cell Lung Cancer

Xiaoqun Nie, Liliang Xia, Fang Gao et al. · Frontiers in Molecular Biosciences · 2021 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Peripheral CD4+ T cell signatures in predicting the responses to anti-PD-1/PD-L1 monotherapy for Chinese advanced non-small cell lung cancer

Liliang Xia, Hui Wang, Mingjiao Sun et al. · Science China Life Sciences · 2021 · 32 citations

Medicine, Immunology, Oncology +16

LRRK2 aggravates kidney injury through promoting MFN2 degradation and abnormal mitochondrial integrity

Shun Zhang, Subo Qian, Hailong Liu et al. · Redox Biology · 2023 · 28 citations · Full text

Life Sciences, Biochemistry, Nephrology +17

Early‐like differentiation status of systemic <scp>PD</scp>‐1⁺<scp>CD8</scp>⁺ T cells predicts <scp>PD</scp>‐1 blockade outcome in non‐small cell lung cancer

Asma Khanniche, Yi Yang, Jie Zhang et al. · Clinical & Translational Immunology · 2022 · 26 citations · Full text

Life Sciences, Immunology, Oncology +16

<i>NLRP4</i> negatively regulates type I interferon response and influences the outcome in anti‐programmed cell death protein (PD)‐1/PD‐ligand 1 therapy

Hui Wang, Liliang Xia, Chengcheng Yao et al. · Cancer Science · 2021 · 22 citations · Full text

Medicine, Immunology, Oncology +17